Recent FDA actions offer long-awaited clarity on what constitutes a ‘minor change’ to solid oral OTC dosage forms, providing manufacturers with a clearer pathway for certain modifications while ...
NEW YORK, NY / ACCESSWIRE / January 7, 2025 / Petros Pharmaceuticals, Inc. (PTPI) ("Petros" or the "Company"), a company focused on expanding consumer access to medication through over-the-counter ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback